medullary thyroid cancer and glp-1 Glucagon-like peptide 1 receptor agonist use risk of cancer: Scandinavian cohort study MCT2D GLP-1 Medications & Thyroid Cancer

It is not FDA-approved and is sold strictly for laboratory and in vitro research use

Of the 85,373 people included, 67,769 had type 2 diabetes and 17,604 people lived with obesity or cardiovascular risk, but without diabetes

While it comes with some potential side effects , most are mild, temporary, and manageable especially when starting with a low dose and following best practices

Data and materials availability Upon request, and subject to certain criteria, conditions, and exceptions (see for more information), Pfizer will provide access to individual de-identified participant data from Pfizer-sponsored global interventional clinical studies conducted for medicines, vaccines and medical devices (1) for indications that have been approved in the US and/or EU or (2) in programs that have been terminated (i.e., development for all indications has been discontinued)